tradingview
Anavex Life Sciences reports preliminary Q2 FY2026 net loss $5.3M, cash $127.4M
Anavex Life Sciences reported preliminary results for the fiscal second quarter ended March 31, 2026, posting a net loss of $5.3 million, or $0.06 per share, compared with a $11.2 million loss in the year-ago quarter. Cash and cash equivalents were $127.4 million as of March 31, 2026, and the compa…